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Management of acute pancreatitis is a hotly debated topic.
Gallstone disease remains the leading aetiology, and the
therapeutic approach in this laparoscopic era relies heavily on
the efforts of endolaparoscopic surgeons. In recent years, there
has been a tendency towards selective rather than routine
performance of endoscopic retrograde cholangiopancreato-
graphy (ERCP) in mild acute biliary pancreatitis, as the selective
policy saves on the costs and risks of unnecessary ERCP
procedures. A recent prospective randomized study reported
that up to 76% of ERCPs in mild biliary pancreatitis were
unnecessary.1 In an attempt to look at this issue in our own
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population, a retrospective study of patients treated in our
institution between January 1998 and December 2000 was
conducted to identify, if any, a subgroup of patients who
would not require routine ERCP investigation.
Patients and methods
Acute pancreatitis was diagnosed if serum amylase was four-
fold greater than normal, in the presence of a compatible
clinical picture. Concurrent cholangitis was diagnosed if body
temperature was elevated to greater than 38.5°C, with jaundice
and/or a positive blood or bile culture. The diagnosis of biliary
pancreatitis was based on demonstration of calculi within the
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OBJECTIVE: The role of endoscopic retrograde cholangiopancreatography (ERCP) in mild acute biliary
pancreatitis is controversial. This study examined the results of ERCP in patients with predicted mild disease and
analysed biochemical and imaging findings in relation to the occurrence of choledocholithiasis.
PATIENTS AND METHODS: There were 172 consecutive patients, admitted between January 1998 and
December 2000, with the diagnosis of acute pancreatitis. All patients were investigated using transcutaneous
ultrasonography and ERCP if biliary aetiology was suspected. Serum bilirubin and alkaline phosphatase were
measured, together with abdominal ultrasonographic findings, as potential predictors for choledocholithiasis.
RESULTS: Biliary calculus was the aetiology in 62.8% of patients (108/172). Among these 108 patients, 79.6%
(86/108) suffered from mild disease. There were only 80 patients who underwent ERCP, and the incidence of
choledocholithiasis was 45% (36/80). Although significant correlation was shown between all three measured
parameters (bilirubin, alkaline phosphatase and ultrasonographic abnormalities) and choledocholithiasis, their
individual sensitivities, specificities and predictive values were low. Nonetheless, if all three tests were normal, the
incidence of ductal stones was significantly lower than that in cases with abnormalities in any one of these
parameters (4.8% vs 59.3%).
CONCLUSION: Routine ERCP is not recommended for patients with mild, acute biliary pancreatitis when there
is no biochemical derangement or ultrasonographic evidence of a dilated biliary system. [Asian J Surg 2003;
26(4):197–201]
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biliary tract or gallbladder by imaging studies and the absence
of other known causes of pancreatitis such as hyperlipidaemia,
hypocalcaemia and abdominal trauma. History of alcoholism
was not considered an exclusion criterion in our study.
Upon admission, all patients were kept fasting and their
blood pressure, pulse and urine output were monitored hourly.
Body temperature was recorded every 4 hours and blood
cultures were taken when body temperature exceeded 38° C.
Intravenous fluid was given according to patients’ hydration
status. Blood tests were performed on admission, 48 hours
after admission, and every other day until the attack subsided.
Transcutaneous abdominal ultrasonography was performed
within 24 hours of admission in most cases. The common bile
duct (CBD) was considered dilated if it was more than 7 mm in
diameter on ultrasound. We adopted Ranson’s criteria for
predicting the severity of pancreatitis.2 In all predicted
severe cases (Ranson’s score > 2) or in those with concomitant
cholangitis, ERCP was performed within 72 hours of admis-
sion.3,4 For mild cases, ERCP was performed in the next
earliest endoscopy section, which was usually more than 72
hours after admission. Patients with severe acute pancreatitis
were transferred to the intensive care unit for close monitoring
and treatment.
Following complete resolution of  symptoms,
cholecystectomy, if not already performed, was scheduled in
the next available elective operating section. All patients
discharged were monitored for any recurrent symptoms or
attacks.
Serum bilirubin and serum alkaline phosphatase were
measured and abdominal ultrasonography was performed for
all patients, as these parameters were considered potential
indicators for choledocholithiasis.5–8 Their measurements were
analysed for any correlation with the ERCP findings. Statistical
analysis was performed using SPSS version 8.0 for Windows




There were 172 consecutive patients treated between January
1988 and December 2000 in the Department of Surgery,
Kwong Wah Hospital, Hong Kong, with a diagnosis of acute
pancreatitis. The aetiology of pancreatitis in 108 patients
(62.8%) was related to biliary stones. The aetiologies of acute
pancreatitis are listed in Table 1. There were 80 male and 92
female patients, with a median age of 64 years (range, 26–93
years). Of the 172 patients, 128 (74.4%) had predicted mild
disease (Ranson’s score, 0–2) and 44 (25.6%) had predicted
severe disease (Ranson’s score > 2). There were 64 (37.2%)
patients who suffered from one or more of the following
medical conditions: hypertension, ischaemic heart disease,
diabetes mellitus, chronic obstructive lung disease and previous
stroke. Concomitant cholangitis occurred in 26 patients (15.1%),
all of whom were in the predicted severe acute pancreatitis
group.
Mild biliary pancreatitis patients
Of the 108 patients with biliary pancreatitis, 86 (79.6%)
presented with predicted mild disease and recovered
uneventfully. Of these 86 patients, ERCP was successfully
performed in 80, five patients refused ERCP and one underwent
surgery due to other intra-abdominal pathology. Of the 80
patients who underwent ERCP, 36 (45%) had ductal stones, all
of which were successfully removed endoscopically. There
was no ERCP-associated mortality. Two cases of post-
sphincterotomy bleeding were controlled by endoscopic means.
The overall complication rate was 2.5% (2/80).
The clinical and biochemical characteristics of patients
with or without ductal stones are listed in Table 2. The
sensitivity, specificity and predictive values of serum bilirubin,
serum alkaline phosphatase and abdominal ultrasonography
in predicting choledocholithiasis are provided in Table 3.
Of the 80 ERCP patients, 44 subsequently underwent
cholecystectomy, with the presence of gallstones confirmed in
all cases, followed by uneventful recovery. Of the remaining 36
patients, 14 had had a previous cholecystectomy, nine refused
surgery, eight had subsequent surgery performed in other
hospitals, and five were not offered surgery because of their
significant medical comorbidities. In the group of patients
Table 1. Aetiology of acute pancreatitis
Aetiology Patients
n (%)




Pancreas divisum 2 (1.2)
Biliary papillomatosis 1 (0.6)
Idiopathic 27 (15.7)
Total 172 (100)
ERCP = endoscopic retrograde cholangiopancreatography.
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lithiasis, and all bile duct stones were removed in one ERCP
session with no mortality and low morbidity (2.5%). Therefore,
for both diagnostic and therapeutic purposes, we believe that
ERCP is an important adjunct in the treatment of acute biliary
pancreatitis.
There is growing evidence to support the policy of selective
ERCP in mild, acute biliary pancreatitis, based on biochemical
and ultrasonographic criteria. A prospective study of 122
patients with acute gallstone pancreatitis demonstrated, in
univariate analysis, significant differences in serum bilirubin
and alkaline phosphatase levels between patients with and
without CBD stones.7 It was further shown, on multivariate
analysis, that serum bilirubin on the second hospital day was
the best predictor of persistent CBD stones.7 Similar findings
were also observed in another study in which none of nine
patients with mild biliary pancreatitis and normal serum
biochemistry had bile duct stones.6 Sees and Martin also
demonstrated in a retrospective study that CBD dilatation on
ultrasound study was highly predictive of biliary stones in
acute pancreatit is ,  though there were no other
clinicobiochemical parameters that correlated with
choledocholithiasis in that study.8 The authors, therefore,
concluded that ERCP is only indicated in mild biliary
pancreatitis patients who present with an ultrasonographic
finding of CBD dilatation.8
All three parameters (serum bilirubin, serum alkaline
phosphatase and abdominal ultrasound) were particularly
examined in our patients. For each, the sensitivity, specificity
and predictive values were not high. It is, therefore, our
suggestion that any single one of these tests is not powerful
enough to predict choledocholithiasis. However, an important
phenomenon occurs when we combine the three tests for
analysis. If there was no elevated serum alkaline phosphatase
or hyperbilirubinaemia, and there was no CBD dilatation on
without choledocholithiasis, there was no subsequent clinical
presentation to us in relation to possibly missed CBD stones
during ERCP.
There were 22 patients with normal serum bilirubin and
alkaline phosphatase upon presentation, and their ultrasound
studies showed no evidence of biliary dilatation. Of these 22
patients, 21 underwent ERCP and further treatment in our
hospital, and only one (4.8%) had choledocholithiasis. On the
contrary, if any one of the three parameters were abnormal, the
incidence of biliary pathology was 59.3%.
Discussion
Gallstone disease was the most common cause of acute
pancreatitis in our study population (62.8%). The role of urgent
or early ERCP is undoubted in severe biliary pancreatitis.3,4
However, the diagnostic yield in mild biliary pancreatitis is
highly variable, at 0% to 58% in recent literature.5,6 In our
study, 45% of mild pancreatitis patients had choledocho-
Table 2. Clinical and biochemical characteristics of patients with or without ductal stones (n = 80)
Patient data Absence of ductal stones Presence of ductal stones p
(n = 44) (n = 36)
Sex, M/F 10/34 18/18 0.087
Median age, yr (range) 63 (31–77) 69 (49–88) 0.11
Elevated serum ALP, n 20 31 < 0.01
Elevated serum bilirubin, n 10 28 < 0.01
Dilated ducts on US
   No 38 12 < 0.01
   Yes 6 24
ALP = alkaline phosphatase; US = ultrasonography.
Table 3. Sensitivity, specificity and predictive values of serum
bilirubin, serum alkaline phosphatase and abdominal
ultrasonography in predicting choledocholithiasis
Measured Serum Serum Transcutaneous
parameters bilirubin alkaline  ultrasonography
(%) phosphatase  (%)
(%)
Sensitivity 77.8 86.1 66.7
Specificity 77.3 54.5 86.4
Positive
  predictive value 73.7 60.8 80.0
Negative
  predictive value 81.0 82.8 76.0
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ultrasound, the incidence of CBD stones was only 4.8% (1/21).
However, if any one of these measurements was abnormal, the
likelihood of choledocholithiasis was 59.3%, which was
significantly higher than 4.8% when all three parameters were
normal (p < 0.01). Therefore, we recommend that the subgroup
of patients with normal biochemical and ultrasound studies
should no longer be indicated for routine ERCP. Other
investigations that are less invasive than ERCP should be
performed as ERCP is associated with considerable morbidity
and mortality.9
Magnetic resonance cholangiopancreatography (MRCP)
is non-invasive and there are more and more studies on the
clinical usefulness of MRCP for the diagnosis of
choledocholithiasis. Although a previous study suggested that
CBD stones of less than 6 mm in diameter could easily be
missed,10 it was recently shown in another large prospective
study that MRCP was highly accurate for the diagnosis of
choledocholithiasis, with a sensitivity of 97.9% and a specificity
of 89.0%.11 MRCP appears to be an accurate non-invasive
technique to image the biliary system, but more studies are
required to consolidate its role and accuracy in the diagnosis
of choledocholithiasis.
Apart from MRCP, endoscopic ultrasonography (EUS) is
also highly accurate in predicting CBD pathology.12–14
According to Liu et al, among their 100 acute pancreatitis
patients, they found that EUS was more sensitive than
transcutaneous ultrasonography in detecting gallbladder
stones.14 More importantly, they demonstrated that EUS was
as accurate as ERCP in detecting the presence of ductal
pathology and that EUS was highly specific (98%) in showing
the absence of choledocholithiasis.14 However, EUS requires
expertise and is highly operator-dependent. Therefore, it is our
belief that MRCP should be the investigation of choice, and
that ERCP and EUS are considered to be too invasive for
patients suffering from only mild pancreatitis.
If  cholecystectomy is required, intraoperative
cholangiography is the alternative to ERCP or other
preoperative imaging techniques to check for ductal stones.
Sees and Martin demonstrated in a retrospective study that
the policy of laparoscopic cholecystectomy (LC) and
intraoperative cholangiography was superior to preoperative
ERCP followed by LC, because the latter group had a significant
prolonged hospital stay, especially if pancreatitis occurred
following the ERCP procedure.8 Nonetheless, the main
criticism of this study was that there was a relatively high rate
of post-ERCP pancreatitis (19%, 6/31), which might have
significantly affected their analysis.
In another study conducted in Europe,15 all (32) patients
with mild pancreatitis were treated with LC and intraoperative
cholangiography, irrespective of any predictors for CBD stones.
Only two patients (6%) were found to have CBD stones and all
were successfully treated laparoscopically. Therefore, the
authors support the policy of omitting preoperative ERCP in
patients with mild biliary pancreatitis.15 However, the overall
incidence of ductal pathology in this European study was very
low when compared to the 45% in our series and the 24% in
another recent report.1 Therefore, it is imprudent to conclude
that ERCP should be totally omitted in all cases of mild
pancreatitis.
In another interesting report using a decision analysis
model, Arguedas et al proposed several strategies for imaging
the biliary system in acute pancreatitis patients before
cholecystectomy, and the cost-effectiveness of each treatment
strategy was examined.16 They found that at a probability of
CBD stones of less than 15%, intraoperative cholangiography
was the least expensive strategy. Thus, they concluded that
intraoperative cholangiography was the preferred and most
cost-effective method to image the biliary system in mild
biliary pancreatitis.16 Taking into account our results and
those from other reports,15,16 it is reasonable to suggest that
mild pancreatitis patients with normal biochemistry and
preoperative ultrasound do not need routine preoperative
ERCP or other imaging modalities, and cholecystectomy should
proceed along with intraoperative cholangiography.
Conclusion
Routine ERCP is not recommended for patients with mild
acute biliary pancreatitis when there is no biochemical
derangement or ultrasonographic evidence of a dilated biliary
system.
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